These results indicate a class effect of GLP-1RAs on neuroprotection in PD
In an early clinical trial, BSO was identified to deplete tumor glutathione levels when administered by continuous infusion but did not demonstrate clinical benefits against cancer (14)
doi: 10.1111/obr.13717, 54
This encouraged scientists to begin investigating whether targeting the central nervous system could provide an effective strategy for weight loss (Capozzi, DiMarchi, Tschpp)
However, GSH treated LT (GSH + LT) stressed seedlings were able to combat the detrimental effects of LT with better SL, RL, FW and DW (Fig
Systems dimension: resilience, crosstalk, and compensation